China has given regulatory approval to researchers to begin conducting clinical trials on humans of an experimental subunit vaccine developed by Chinese scientists against the Covid-19 coronavirus.
State-owned broadcaster China Central Television reported on 17 March that the experimental vaccine, which had been approved for clinical trials the previous day, was developed by scientists from China's Academy of Military Medical Sciences, which is affiliated to the People's Liberation Army (PLA), as part of an effort led by senior bio-engineer Major General Chen Wei.
The report said that Maj Gen Chen and her team - with the help of local companies - had been working on the development of the subunit vaccine since arriving in the Chinese city of Wuhan, where the Covid-19 outbreak was first documented in late January.
Want to read more? For analysis on this article and access to Jane's unrivalled data and insight, learn more about our subscription options at janes.com/products